Title : Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication.

Pub. Date : 2021 Feb 18

PMID : 33602908






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ibrutinib inhibits Bruton tyrosine kinase while venetoclax is a specific inhibitor of the anti-apoptotic protein BCL2. ibrutinib Bruton tyrosine kinase Homo sapiens